Patients with multiple myeloma with the shortest survival have the most kidney damage
Platelet-rich plasma treatment shows efficacy for osteoarthritis
30 August 2021For transplants, COVID complicates the race against time
31 August 2021Patients with multiple myeloma with the shortest survival have the most kidney damage
Nearly 20% of patients with multiple myeloma have a form in which they make extreme quantities of one component of the abnormal antibody they are producing, and these so-called “free monoclonal light chains” pile up and damage the kidneys, investigators say.
